The Almaty Endocrinology Forum 2026 brought together leading specialists from Kazakhstan, Uzbekistan, Belarus, South Korea, India and other countries to discuss the current landscape of endocrinology, diabetology and metabolic medicine. Sona Academy digitised the most clinically relevant sessions of the two-day programme and organised them into a single multidisciplinary course covering type 1 and 2 diabetes, obesity, metabolic syndrome, metabolic-associated fatty liver disease and their vascular, ophthalmic and neurological complications. The course includes an interview with Dr. Zhanay Akanov on the one-window multidisciplinary team and the digital diabetes agenda for Central Asia, and features Kazakhstan's first Patient Day — a live dialogue between patients and a panel of endocrinologists, vascular surgeons and ophthalmologists. All materials are non-promotional, contain no trade names and no patient personal data, and are available in closed access to verified medical professionals only.
Apply current criteria for metabolic syndrome, prediabetes and metabolic-associated fatty liver disease; identify cardiovascular and hepatic risk early and select the right follow-up intensity.
Choose insulin regimens, GLP-1 and dual GLP-1/GIP receptor agonists, and weight-modifying therapy based on the patient's clinical profile, comorbidities and treatment goals.
Set up the correct frequency and scope of screening for diabetic retinopathy, neuropathy, nephropathy and the diabetic foot; apply protocols for early intervention across specialties.
Coordinate endocrinologists, cardiologists, vascular surgeons, gastroenterologists and ophthalmologists into a one-window team; align referral criteria and handoffs across primary and specialty care.
Understand where beta-cell transplantation, glucagon-plus-insulin biological pumps, AI-based retinopathy screening and next-generation continuous glucose monitoring fit into today's clinical decisions.
Dr. Zhanay Akanov, a leading figure in Kazakhstan's endocrine community, on the multidisciplinary 'one-window' approach to diabetes care, digital tools and AI in clinical endocrinology, the prospect of an artificial pancreas, and the agenda of the 2026 Almaty Endocrinology Congress.






Educational use only. This program is provided by Sona Academy for educational and informational purposes for healthcare professionals and students only. It is not intended for patients or the general public, is not a substitute for professional medical advice, diagnosis or treatment, and is not intended to promote the use of any products.
Funding & editorial independence. The sponsor does not participate in or influence the selection, development or content of the program. The content is developed by the speaker, and the opinions expressed are the speaker's and do not necessarily reflect those of Sona Academy or the sponsor.
Jurisdictional differences. Laws, regulations and ethical standards governing medical practice vary by country, and not all methods or techniques presented may be permissible in every jurisdiction. Users are responsible for ensuring compliance with all laws, regulations, licensing requirements and professional standards applicable in their jurisdiction.
The speakers have declared no relevant conflicts of interest in relation to this presentation.


Tell us which topics matter most to You, which learning formats You prefer, and which speakers You would like to hear from. Complete the short survey and influence future educational initiatives of Sona Academy.
